Nuveen’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$519K Buy
169,156
+779
+0.5% +$3.37K ﹤0.01% 2822
2025
Q4
$599K Hold
168,377
﹤0.01% 2807
2025
Q3
$1.5M Hold
168,377
﹤0.01% 2426
2025
Q2
$1.55M Sell
168,377
-20,664
-11% -$176K ﹤0.01% 2414
2025
Q1
$1.62M Buy
189,041
+10,076
+6% +$95.1K ﹤0.01% 2424
2024
Q4
$1.92M Hold
178,965
﹤0.01% 2406
2024
Q3
$1.02M Sell
178,965
-125,200
-41% -$722K ﹤0.01% 2752
2024
Q2
$1.28M Buy
304,165
+38,373
+14% +$155K ﹤0.01% 2604
2024
Q1
$1.35M Buy
265,792
+25,351
+11% +$143K ﹤0.01% 2571
2023
Q4
$2.24M Buy
240,441
+13,819
+6% +$95.1K ﹤0.01% 2362
2023
Q3
$1.48M Buy
226,622
+14,155
+7% +$113K ﹤0.01% 2414
2023
Q2
$1.73M Buy
212,467
+1,065
+0.5% +$9.13K ﹤0.01% 2415
2023
Q1
$1.81M Sell
211,402
-9,678
-4% -$96.6K ﹤0.01% 2369
2022
Q4
$2.05M Sell
221,080
-50,375
-19% -$538K ﹤0.01% 2380
2022
Q3
$2.8M Sell
271,455
-3,575
-1% -$37.7K ﹤0.01% 2216
2022
Q2
$2.75M Buy
275,030
+1,299
+0.5% +$12.3K ﹤0.01% 2275
2022
Q1
$3.43M Buy
273,731
+29,603
+12% +$364K ﹤0.01% 2264
2021
Q4
$4.23M Buy
244,128
+18,460
+8% +$351K ﹤0.01% 2220
2021
Q3
$4.05M Sell
225,668
-9,150
-4% -$182K ﹤0.01% 2328
2021
Q2
$5.37M Sell
234,818
-16,789
-7% -$249K ﹤0.01% 2203
2021
Q1
$3.76M Buy
251,607
+49,915
+25% +$545K ﹤0.01% 2307
2020
Q4
$1.09M Buy
201,692
+1,605
+0.8% +$8.46K ﹤0.01% 2772
2020
Q3
$910K Buy
200,087
+909
+0.5% +$3.91K ﹤0.01% 2728
2020
Q2
$980K Sell
199,178
-12,512
-6% -$47.3K ﹤0.01% 2633
2020
Q1
$667K Buy
211,690
+101,495
+92% +$354K ﹤0.01% 2669
2019
Q4
$285K Hold
110,195
﹤0.01% 3024
2019
Q3
$348K Hold
110,195
﹤0.01% 3028
2019
Q2
$372K Buy
+110,195
New +$342K ﹤0.01% 3088

Other funds holding AVXL